TARYN THOMPSON: Open Payments
NPI 1558639567 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,808 in 95 payments from 34 companies in 2025. Trend: 2023 $2,599 · 2024 $2,396 · 2025 $2,808
Food & beverage: $1,730Speaker / faculty: $454Travel & lodging: $454Education: $170
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $909 |
| Janssen Biotech, Inc. | 14 | $232 |
| Celgene Corporation | 9 | $182 |
| Novartis Pharmaceuticals Corporation | 9 | $165 |
| PFIZER INC. | 6 | $120 |
| SEAGEN INC. | 1 | $100 |
| Daiichi Sankyo Inc. | 4 | $95 |
| Caris MPI, Inc. | 2 | $94 |
| Incyte Corporation | 4 | $82 |
| Merck Sharp & Dohme LLC | 3 | $58 |
Products named: REBLOZYL, DARZALEX, MI CANCER SEEK, XYNTHA, Fabhalta, KEYTRUDA, BESREMI, RYBREVANT.
Industry payments across OR — which companies pay providers there.
